novo glp 1 pill Lilly launches GLP-1 pill, kicking off showdown with Nordisk Wegovy® Pill 25 mg |

Legal escalation in February centered on allegations that Hims & Hers marketed unapproved versions of Wegovy/Ozempic, raising patient-safety and IP concerns while bypassing FDA review standards

By comparison, the STEP 1 trial for semaglutide reported 14.9% at 68 weeks, and SURMOUNT-1 for tirzepatide reported 20.9% at 72 weeks

Featured Resources Life-changing weight loss that lasts Ready to learn more

For most people yes

GLP-1 face has become a familiar phrase among those using semaglutide or tirzepatide

Rather than strict protocols, we create a dynamic treatment journey that continuously adapts to your changing face, combining different elements of our treatment toolkit in the most effective way for your unique situation